药师参与1例颅内多重耐药鲍曼不动杆菌感染病例的治疗  

Participation of Clinical Pharmacists in the Drug Treatment of One Patient with Multidrug-resistant Acinetobacter Baumannii Meningitis Intracranial Infection

作　　者：刘璐[1] 李希娜[1] 赵爽[1] 赵文婷[1] 海鑫 

机构地区：[1]哈尔滨医科大学附属第一医院药学部,哈尔滨150001

出　　处：《中国药师》2016年第10期1925-1926,1958,共3页China Pharmacist

摘　　要：目的:临床药师通过参与1例鲍曼不动杆菌导致颅内感染患者的治疗过程,探索最佳的药物治疗方案。方法:临床药师参加治疗团队,参与患者治疗方案的设计,从药物的选择、给药剂量、途径及不良反应(ADR)方面对患者进行个体化给药。结果:选择敏感抗菌药物,成功的治疗颅内多重耐药鲍曼不动杆菌感染。鲍曼不动杆菌引起的颅内感染,头孢哌酮舒巴坦钠、米诺环素都可以作为有效治疗药物。结论:临床药师参与临床会诊,医师与药师互相协作,保证了患者用药的安全、有效、经济。Objective： To explore best drug treatment regimen through the participation of clinical pharmacists in the drug treat- ment of one patient with multidrug-resistant Acinetobacter baumannii meningitis intracranial infection. Methods ： Clinical pharmacists joined in the treatment team and designed the treatment plan. The individualized dosage regimen was made out through the choices of drugs, dose and administration route, and taking the ADR of drugs into consideration. Results： The intraeranial muhidrug-resistant Acinetobacter baumannii infection was controlled by the sensitive antibiotics. Cefoperazone sulbaetam and minocycline were both effec- tive in the treatment of Acinetobacter baumannii intracranial infection. Conclusion： Clinical pharmacists should provide clinical consul- tation for physicians to ensure the safety, effectiveness and economic of patients＇ medication.

关 键 词：临床药师 鲍曼不动杆菌 颅内感染 

分 类 号：R97[医药卫生—药品]